A5022041820- Inflammatory Bowel Disease
- Microscopic Colitis
- Eosinophilic Esophagitis
- Health Systems, Economic Evaluations, Quality of Life
- Diverticular Disease and Complications
- Nutrition and Health in Aging
- Venous Thromboembolism Diagnosis and Management
- Helicobacter pylori-related gastroenterology studies
- Esophageal and GI Pathology
- Pregnancy and Medication Impact
- Frailty in Older Adults
- Clinical Nutrition and Gastroenterology
- Healthcare cost, quality, practices
- Celiac Disease Research and Management
- Gastrointestinal Bleeding Diagnosis and Treatment
- Autoimmune and Inflammatory Disorders
- Immunodeficiency and Autoimmune Disorders
- COVID-19 Clinical Research Studies
- Gastrointestinal disorders and treatments
- Clostridium difficile and Clostridium perfringens research
- COVID-19 and healthcare impacts
- Gastric Cancer Management and Outcomes
- Gastrointestinal motility and disorders
- Nosocomial Infections in ICU
- Diversity and Career in Medicine
New York University
2021-2025
NYU Langone Health
2021-2025
Icahn School of Medicine at Mount Sinai
2021-2022
Columbia University Irving Medical Center
2016-2021
Texas Health Dallas
2019-2021
Mount Sinai Hospital
2020-2021
Mount Sinai Hospital
2021
New York Hospital Queens
2018-2020
Columbia University
2019-2020
NewYork–Presbyterian Hospital
2018-2020
Abstract Objective: To examine associations between sociodemographic and mental health characteristics with household risk for food insecurity during the COVID-19 outbreak. Design: Cross-sectional online survey analysed using univariable tests a multivariable logistic regression model. Setting: The United States week of 30 March 2020. Participants: A convenience sample 1965 American adults Amazon’s Mechanical Turk platform. Participants reporting prior to pandemic were excluded from...
Background There is an increasing incidence of inflammatory bowel disease (IBD) for which environmental factors are suspected. Antibiotics have been associated with development IBD in earlier generations, but their influence on risk adults uncertain. Objective To assess the impact antibiotic exposure, including dose–response, timing and class, all individuals aged ≥10 years. Design Using Denmark nationwide registries, a population-based cohort residents years was established between 2000...
Summary Background Venous thromboembolism (VTE) is a significant cause of morbidity and mortality among patients with inflammatory bowel disease (IBD). However, data on national trends remain limited. Aims To assess in VTE‐associated hospitalisations IBD as well risk factors for, associated with, these events Methods Using the U.S. Nationwide Inpatient Sample from 2000–2018, temporal VTE were assessed using National Cancer Institute's Joinpoint Regression Program estimates presented average...
Abstract Background Although surgery is often reserved for individuals with refractory Crohn’s disease (CD), recent data suggest that intestinal resection in select may obviate the need future CD-related treatment, particularly among older adults. Despite this, limited characterizing these patients exist. Methods We performed a nationwide cohort study using Swedish National Patient Register and ESPRESSO (Epidemiology Strengthened by histoPathology Reports Sweden) to identify all who...
Abstract Background Mirikizumab (MIRI), an anti-IL-23p19 antibody, has demonstrated efficacy and safety in adults with moderately to severely active ulcerative colitis (UC) two Phase 3 trials (LUCENT-1/-2; NCT03518086, NCT03524092). [1] As novel therapies for UC are not well studied ≥60 years (older adults), we aimed evaluate the of MIRI compared placebo (PBO) during induction maintenance treatment among this especially vulnerable subgroup patients UC. [2. 3] Methods In LUCENT-1, were...
Abstract Background Environmental factors, which play a critical role in the rising incidence of inflammatory bowel disease (IBD), may hold key for prevention. Statins, known their cardiovascular benefits, possess anti-inflammatory properties and have been hypothesized to reduce risk developing IBD, though prior data limited. Thus, advance what is known, we prospectively assessed association between statin use IBD among individuals eligible therapy. Methods Using prospective new user design...
Introduction: In the general population, right I-sided dysplasia presents a higher risk for colorectal cancer (CRC) and metachronous compared to left (L)-sided dysplasia. Given that patients with inflammatory bowel disease (IBD) are at than we sought assess factors as well differences in outcomes between R-sided, L-sided, both R- L-sided Methods: A retrospective chart review was performed on NYU Langone Health who had evidence of colonoscopy 2011 2021. Demographics pertinent medical history...
Abstract BACKGROUND: Targeting the tumor microenvironment and angiogenesis is a novel lymphoma therapeutic strategy. The authors report safety, activity, angiogenic profiling results with rituximab thalidomide plus prednisone, etoposide, procarbazine, cyclophosphamide (RT‐PEPC) regimen in patients recurrent mantle cell (MCL). METHODS: RT‐PEPC included induction (Months 1‐3) of 4 times weekly, daily (50 mg), PEPC followed by maintenance (100 oral titrated to neutrophil count, every months....
Abstract Background Despite increased risk of venous thromboembolism (VTE) among hospitalized patients with inflammatory bowel disease (IBD), pharmacologic prophylaxis rates remain low. We sought to understand the reasons for this by assessing factors associated VTE in IBD and safety its use. Methods This was a retrospective cohort study conducted between January 2013 August 2018. The primary outcome prophylaxis, exposures interest included acute chronic bleeding. Medical records were parsed...
INTRODUCTION: Older adults with inflammatory bowel disease (IBD) are at higher risk for postoperative complications as compared to their younger counterparts; however, factors contributing this unknown. We assessed associated adverse IBD-related surgical outcomes, evaluated trends in emergency surgery, and explored differential risks by age. METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program database, we identified ≥18 years age who underwent an...
Background & AimsOur understanding of outcomes and disease time course COVID-19 in patients with gastrointestinal (GI) symptoms remains limited. In this study we characterize the severity among hospitalized manifestations a large, diverse cohort from Unites States.MethodsThis retrospective evaluated individuals between March 11 April 28, 2020 at two affiliated hospitals New York City. We association GI death, also explored duration, symptom onset to death or discharge.ResultsOf 2804...
Objective. To examine the effect of autoimmune (AI) disease on composite outcome intensive care unit (ICU) admission, intubation, or death from COVID-19 in hospitalized patients. Methods. Retrospective cohort study 186 patients with between March 1, 2020, and April 15, 2020 at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center. The included 62 AI 124 age- sex-matched controls. primary was a ICU death, secondary as time to in-hospital death. Baseline demographics,...